tiprankstipranks
Cidara Therapeutics (CDTX)
NASDAQ:CDTX

Cidara Therapeutics (CDTX) Stock Investors

693 Followers
Based on 730,878 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CDTX
On average, investors allocate 3.86% of their portfolios to CDTX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 730,878 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CDTX

1.1%
Last 7
Days
10.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CDTX, out of 730,878 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CDTX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.57%
Increased
17.38%
$14.76
Based on the activity of 13,742 investors who made their portfolios public
The table shows changes in CDTX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CDTX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
GE Aerospace
5.53%
<+0.01%
+12.57%
177.71B
Industrials
Marathon Digital Holdings
5.62%
-0.68%
+0.20%
5.49B
Financial
Enterprise Products Partners
5.78%
-0.62%
+0.74%
63.01B
Energy
Blink Charging Co
5.07%
-1.11%
-4.29%
244.40M
Industrials
Assertio Therapeutics
2.65%
-1.27%
-5.47%
78.78M
Healthcare
Coherus Biosciences
2.62%
-1.32%
-5.31%
231.54M
Healthcare
AMC Entertainment
5.52%
-1.14%
-3.31%
942.48M
Communication Services
Plug Power
4.90%
-0.97%
-3.59%
1.65B
Industrials
Riot Platforms
5.19%
-0.41%
+4.45%
3.02B
Financial
Merck & Company
4.16%
+0.15%
+1.94%
332.28B
Healthcare
Based on the activity of 730,878 active portfolios
Open your Smart Portfolio

CDTX Investor Analysis

CDTX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.6%
of CDTX holders
are under 35
Average Segment Performance
Average P/E Ratio56.32
Beta6.59
Dividend Yield6.13%
CDTX investors between 35–55

Between 35–55

10.6%
Last 30 days
Holdings Change
54.3%
of CDTX holders
are between 35–55
Average Segment Performance
Average P/E Ratio61.35
Beta11.34
Dividend Yield17.67%
CDTX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
38.1%
of CDTX holders
are over 55
Average Segment Performance
Average P/E Ratio52.26
Beta4.21
Dividend Yield22.32%
Overview of age group and performance of CDTX stock investors
See who invests in CDTX according to age group and performance.

FAQ

How many retail Investors hold CDTX?
<0.1% of TipRanks' retail investors hold CDTX in their portfolios.
    What is CDTX Investor Sentiment?
    CDTX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CDTX in the last 7 days?
      ▲ 1.1% of TipRanks' retail investors changed their holding of CDTX in the last 7 days.
        What percentage of retail investors changed their holding of CDTX in the last 30 days?
        ▲ 10.2% of TipRanks' retail investors changed their holding of CDTX in the last 30 days.
          What is the average age of retail investors who hold CDTX?
          The average age of CDTX Holders is between 35–55.
            What other stocks have CDTX investors also bought?
            CDTX Investors also bought GE, MARA, EPD, BLNK, ASRT, CHRS, AMC, PLUG, RIOT, MRK.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CORTCorcept Therapeutics
              GERNGeron
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis